<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03376295</url>
  </required_header>
  <id_info>
    <org_study_id>0205-0538</org_study_id>
    <nct_id>NCT03376295</nct_id>
  </id_info>
  <brief_title>Comparative Effectiveness of COPD Treatments</brief_title>
  <official_title>Comparative Effectiveness of Combination Therapies in COPD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boehringer Ingelheim</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boehringer Ingelheim</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the effectiveness of maintenance treatment of Chronic obstructive pulmonary disease
      (COPD) with the combination of a long-acting bronchodilators (LABA and the LAMA tiotropium
      (LABA-TIO)) compared with the combination of a LABA and an ICS (LABA-ICS) on the time to COPD
      exacerbation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 1, 2017</start_date>
  <completion_date type="Actual">December 31, 2017</completion_date>
  <primary_completion_date type="Actual">December 31, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of events hospitalised for severe exacerbation or prescribed with oral coticosteriod, Prednisolone for moderate exacerbation</measure>
    <time_frame>12 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>rate of COPD exacerbations</measure>
    <time_frame>12 years</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">3000</enrollment>
  <condition>Pulmonary Disease, Chronic Obstructive</condition>
  <arm_group>
    <arm_group_label>Subjects diagnosed with COPD</arm_group_label>
    <description>Chronic obstructive pulmonary disease</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>LABA and the LAMA tiotropium (LABA-TIO)</intervention_name>
    <description>combinational drug</description>
    <arm_group_label>Subjects diagnosed with COPD</arm_group_label>
    <other_name>FORVENT, SPIRIVA, SRIVASSO</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>LABA and an ICS (LABA-ICS)</intervention_name>
    <description>combinational drug</description>
    <arm_group_label>Subjects diagnosed with COPD</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The base cohort will consist of all patients with a diagnosis of COPD from 1 January 1995
        until 31 December 2015 who subsequently received at least one prescription for a
        long-acting bronchodilator, either LABA or tiotropium, or for an inhaled corticosteroid,
        alone or in combination, from 1 January 2002 until 31 December 2015.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  New users of long-acting bronchodilators, LABA and tiotropium on the same date or of
             LABA and ICS, either as a fixed-dose combination or free combination, on the same date
             between January 2002 and December 2015

          -  Diagnosis of COPD and age â‰¥ 55 years

        Exclusion Criteria:

          -  Less than one year of medical history information prior to the date of combined
             treatment initiation (cohort entry)

          -  Asthma diagnosis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Centre for Clinical Epidemiology, McGill University</name>
      <address>
        <city>Montreal</city>
        <zip>H3T 1E2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 30, 2017</study_first_submitted>
  <study_first_submitted_qc>December 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 18, 2017</study_first_posted>
  <last_update_submitted>April 20, 2018</last_update_submitted>
  <last_update_submitted_qc>April 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Chronic Disease</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tiotropium Bromide</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

